Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atrial arrhythmias.

× No keyword cloud information.

27 in total

1. Safety of an intravenous second generation contrast agent in patients with severe left ventricular dysfunction.

Authors: P Soman; A Lahiri; R Senior
Journal: Heart Date: 2000-12 Impact factor: 5.994

2. Intravenous amiodarone bolus immediately controls heart rate in patients with atrial fibrillation accompanied by severe congestive heart failure.

Authors: R Hofmann; G Wimmer; F Leisch
Journal: Heart Date: 2000-12 Impact factor: 5.994

Review 3. Atrial fibrillation: is rate stabilization a valid clinical strategy?

Authors: S H Hohnloser
Journal: Ann Noninvasive Electrocardiol Date: 2001-04 Impact factor: 1.468

4. The relationship between P wave dispersion and diastolic dysfunction.

Authors: Huseyin Gunduz; Emrah Binak; Huseyin Arinc; Ramazan Akdemir; Hakan Ozhan; Ali Tamer; Cihangir Uyan
Journal: Tex Heart Inst J Date: 2005

Review 5. Choosing the right beta-blocker. A guide to selection.

Authors: J R Hampton
Journal: Drugs Date: 1994-10 Impact factor: 9.546

6. Recovery of atrial systolic function after pharmacological conversion of chronic atrial fibrillation to sinus rhythm: a Doppler echocardiographic study.

Authors: A Jović; R Troskot
Journal: Heart Date: 1997-01 Impact factor: 5.994

7. Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.

Authors: H J Crijns; I C Van Gelder; R G Tieleman; J Brügemann; P J De Kam; A T Gosselink; M T Bink-Boelkens; K I Lie
Journal: Heart Date: 1997-01 Impact factor: 5.994

Review 8. Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors: Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal: Drugs Date: 2002 Impact factor: 9.546

Review 9. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.

Authors: Giuseppe Boriani; Mauro Biffi; Igor Diemberger; Cristian Martignani; Angelo Branzi
Journal: Drugs Date: 2003 Impact factor: 9.546

10. Rationale for and design of the CREATIVE-AF trial: randomized, double-blind, placebo-controlled, crossover study of the effect of irbesartan on oxidative stress and adhesion molecules in patients with persistent atrial fibrillation.

Authors: Andreas Goette; Alessandra D'Alessandro; Alicja Bukowska; Siegfried Kropf; Christian Mewis; Christoph Stellbrink; Jürgen Tebbenjohanns; Christian Weiss; Uwe Lendeckel
Journal: Clin Drug Investig Date: 2008 Impact factor: 2.859